Funding the future or falling behind? EU’s 10 billion biotech bet

EU PERSPECTIVES - Europe's biotech future is at a crossroads. With €10 billion on the table, the European Commission is racing to show that its funding plans and new incentives will actually drive innovation—before global rivals pull ahead. MEPs are demanding clear evidence that the money will deliver results for both investors and public health. Read more

Europe is in the last minute to save the still existing biotech competitive edge, commissioner Olivér Várhelyi says / Photo: Unsplash